Christelle Durand

Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis

A. Falsey, Shinn-Jang Hwang, G. Feldman, 2016, Human vaccines & immunotherapeutics.

Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

J. Richardus, J. Devaster, L. Rombo, 2013, BMC Infectious Diseases.

Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study.

L. Denny, D. Descamps, C. Hervé, 2013, Vaccine.

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial.

A. Falsey, A. Nowakowski, Shinn-Jang Hwang, 2013, The Lancet. Infectious diseases.

Bacterial contamination in the environment of hospitalised children with cystic fibrosis.

P. Berche, I. Sermet-Gaudelus, G. Lenoir, 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines

A. Falsey, R. Osborne, G. Feldman, 2014, Influenza and other respiratory viruses.

A multi-criteria decision making approach to identify a vaccine formulation

Walthère Dewé, Lidia Oostvogels, Christelle Durand, 2016, Journal of biopharmaceutical statistics.

Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18–25 years enrolled in a clinical trial

Juan Li, F. Zhu, F. Struyf, 2014, International journal of cancer.